SEC Form 4 · accession 0001012975-18-000229
Altimmune, Inc. · ALT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
M Scot Roberts
Officer — Chief Scientific Officer
Period of report
Jun 6, 2017
Accepted (ET)
Feb 23, 2018 · 4:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326190
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 | Jun 6, 2017 | P | 449 | $4.42 | A | 449 | I | Shares held by spouse of Reporting Person |
Table II — derivative securities
No Table II lines on this filing.